Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial
Authors:
- Søren GullaksenSGSøren Gullaksen
- Liv VernstrømLVLiv Vernstrøm
- Steffen Skovgaard SørensenSSSteffen Skovgaard Sørensen
- Kristian Løkke FunckKFKristian Løkke Funck
- Per Løgstrup PoulsenPPPer Løgstrup Poulsen
- Esben LaugesenELEsben Laugesen
Open Access
- 29 August 2026
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 40 (10)
Abstract
No abstract availableFunding Information
- Lægeforeningen (2019-3780/41)
- Novo Nordisk Fonden (NNF170C0029064)
- Region Midtjylland (A3192)
This publication has 27 references indexed in Scilit:
- Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart FailureJAMA Cardiology, 2025
- Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED)Diabetes & Metabolism, 2023
- Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trialDiabetologia, 2023
- Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trialDiabetologia, 2021
- Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and DiabetesKidney International Reports, 2021
- Association between circulating cell adhesion molecules and risk of type 2 diabetes: A meta-analysisAtherosclerosis, 2019
- Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney diseaseDiabetologia, 2019
- Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective StudyDiabetes Therapy, 2019
- Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implicationsReviews in Endocrine and Metabolic Disorders, 2010
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999